Biogen (BIIB) Current Taxes (2009 - 2026)

Biogen has reported Current Taxes for 18 years, with the latest figure at $86.9 million in Q2 2026.

• On a quarterly basis, Current Taxes fell 24.3% year-over-year to $86.9 million in Q2 2026; TTM through Jun 2026 was $86.9 million, a 24.3% decrease from a year earlier, with the FY2025 full-year figure at $114.8 million, down 79.06% from the prior year.
• Current Taxes was $86.9 million for Q2 2026 at Biogen, down from $93.6 million in the prior quarter.
• The five-year high for Current Taxes was $626.1 million in Q1 2025, with the low at $86.9 million in Q2 2026.
• Average Current Taxes over 5 years is $266.4 million, with a median of $250.6 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Current Taxes jumped 170.8% in 2025, then slumped 85.05% in 2026.
• Over 5 years, Current Taxes stood at $259.9 million in 2022, then declined by 0.96% to $257.4 million in 2023, then surged by 113.01% to $548.3 million in 2024, then sank by 79.06% to $114.8 million in 2025, then dropped by 24.3% to $86.9 million in 2026.
• The last three Current Taxes figures came in at $86.9 million (Q2 2026), $93.6 million (Q1 2026), and $114.8 million (Q4 2025), per Business Quant data.